
### [NCIT:C2912](http://purl.obolibrary.org/obo/NCIT_C2912)
**Label:** Burkitt Lymphoma

**Subclasses:** [NCIT:C5008](http://purl.obolibrary.org/obo/NCIT_C5008) (Recurrent Burkitt Lymphoma), [NCIT:C27410](http://purl.obolibrary.org/obo/NCIT_C27410) (Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma), [NCIT:C7309](http://purl.obolibrary.org/obo/NCIT_C7309) (Splenic Burkitt Lymphoma), [NCIT:C27694](http://purl.obolibrary.org/obo/NCIT_C27694) (EBV-Related Burkitt Lymphoma), [NCIT:C8139](http://purl.obolibrary.org/obo/NCIT_C8139) (Stage III Adult Burkitt Lymphoma), [NCIT:C27914](http://purl.obolibrary.org/obo/NCIT_C27914) (Sporadic Burkitt Lymphoma), [NCIT:C7245](http://purl.obolibrary.org/obo/NCIT_C7245) (Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8159](http://purl.obolibrary.org/obo/NCIT_C8159) (Recurrent Adult Burkitt Lymphoma), [NCIT:C27915](http://purl.obolibrary.org/obo/NCIT_C27915) (Immunodeficiency-Related Burkitt Lymphoma), [NCIT:C7189](http://purl.obolibrary.org/obo/NCIT_C7189) (Burkitt Lymphoma with Plasmacytoid Differentiation), [NCIT:C7244](http://purl.obolibrary.org/obo/NCIT_C7244) (Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8850](http://purl.obolibrary.org/obo/NCIT_C8850) (Stage III Burkitt Lymphoma), [NCIT:C5084](http://purl.obolibrary.org/obo/NCIT_C5084) (Stage IV Burkitt Lymphoma), [NCIT:C9189](http://purl.obolibrary.org/obo/NCIT_C9189) (Recurrent Childhood Burkitt Lymphoma), [NCIT:C9187](http://purl.obolibrary.org/obo/NCIT_C9187) (Stage III Childhood Burkitt Lymphoma), [NCIT:C7188](http://purl.obolibrary.org/obo/NCIT_C7188) (Classical Burkitt Lymphoma), [NCIT:C9188](http://purl.obolibrary.org/obo/NCIT_C9188) (Stage IV Childhood Burkitt Lymphoma), [NCIT:C9095](http://purl.obolibrary.org/obo/NCIT_C9095) (Childhood Burkitt Lymphoma), [NCIT:C8080](http://purl.obolibrary.org/obo/NCIT_C8080) (Stage I Adult Burkitt Lymphoma), [NCIT:C6917](http://purl.obolibrary.org/obo/NCIT_C6917) (Atypical Burkitt/Burkitt-Like Lymphoma), [NCIT:C8849](http://purl.obolibrary.org/obo/NCIT_C8849) (Stage II Burkitt Lymphoma), [NCIT:C27465](http://purl.obolibrary.org/obo/NCIT_C27465) (Colon Burkitt Lymphoma), [NCIT:C8847](http://purl.obolibrary.org/obo/NCIT_C8847) (Refractory Burkitt Lymphoma), [NCIT:C8848](http://purl.obolibrary.org/obo/NCIT_C8848) (Stage I Burkitt Lymphoma), [NCIT:C8126](http://purl.obolibrary.org/obo/NCIT_C8126) (Stage II Adult Burkitt Lymphoma), [NCIT:C27409](http://purl.obolibrary.org/obo/NCIT_C27409) (Small Intestinal Burkitt Lymphoma), [NCIT:C5251](http://purl.obolibrary.org/obo/NCIT_C5251) (Gastric Burkitt Lymphoma), [NCIT:C9185](http://purl.obolibrary.org/obo/NCIT_C9185) (Stage I Childhood Burkitt Lymphoma), [NCIT:C9186](http://purl.obolibrary.org/obo/NCIT_C9186) (Stage II Childhood Burkitt Lymphoma), [NCIT:C8152](http://purl.obolibrary.org/obo/NCIT_C8152) (Stage IV Adult Burkitt Lymphoma), [NCIT:C9062](http://purl.obolibrary.org/obo/NCIT_C9062) (Adult Burkitt Lymphoma), [NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma), [NCIT:C96502](http://purl.obolibrary.org/obo/NCIT_C96502) (Colorectal Burkitt Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 54.38%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39811](http://purl.obolibrary.org/obo/NCIT_C39811) (t(5;11)(q35;q13)))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39809](http://purl.obolibrary.org/obo/NCIT_C39809) (Type 1 Renal Papillary Adenoma))) 37.02%


